The Defense Logistics Agency (DLA) awarded a $4,311.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The delivery order is for the supply of 120 capsules of the prescription drug Xtandi 40 mg, with a completion date of December 19, 2024. DMS Pharmaceutical Group has demonstrated its capability to provide diverse pharmaceutical products to support the medical supply needs of military healthcare facilities and veterans' medical centers nationwide.
Generated 3/23/25, 12:53 AM